( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
1313.3
1338.1
1534.6
1778.3
Total Expenditure
1419.2
1400.7
1610
1851.8
PBIDT (Excl OI)
-105.9
-62.60
-75.40
-73.5
Other Income
7.7
33.1
15.6
67.6
Operating Profit
-98.19
-29.5
-59.8
-5.89
Exceptional Items
-46
NA
NA
NA
PBDT
-214.7
-94.4
-121.3
-54.59
Depreciation
51.8
47
45.4
40.6
Profit Before Tax
-266.5
-141.4
-166.7
-95.19
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-266.5
-141.4
-166.7
-95.19
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-266.5
-141.4
-166.7
-95.19
Minority Interest
NA
NA
NA
NA
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-266.5
-141.4
-166.7
-95.2
Equity Capital
167.4
167.4
167.4
167.4
Calculated EPS
-3.18
-1.68
-1.99
-1.13
Calculated EPS (Annualised)
-12.73
-6.75
-7.96
-4.54
No of Public Share Holdings
20960027
20960027
20960027
20960027
% of Public Share Holdings
25.04
25.04
25.04
25.04
PBIDTM% (Excl OI)
-8.06
-4.67
-4.91
-4.13
PBIDTM%
-7.47
-2.20
-3.89
-0.33
PBDTM%
-16.34
-7.05
-7.90
-3.07
PBTM%
-20.29
-10.56
-10.86
-5.35
PATM%
-20.29
-10.56
-10.86
-5.35